Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide therapy for cicatricial pemphigoid.

Daihung Jay Duong1, Richard T Moxley, Robert M Kellman

  • 1Department of Neurology, State University of New York at Syracuse, USA.

Journal of the American Academy of Dermatology
|July 26, 2002
PubMed
Summary

Cicatricial pemphigoid, an autoimmune blistering disease, can cause scarring. Thalidomide effectively controlled this previously resistant condition in a reported case.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical Leukoderma after Allergic Contact Dermatitis and Patch Testing.

Dermatitis : contact, atopic, occupational, drug·2025
Same author

Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy.

Neurology. Genetics·2025
Same author

Toll-Like Receptors and Contact Dermatitis.

Dermatitis : contact, atopic, occupational, drug·2024
Same author

Safety assessment for nail cosmetics: Framework for the estimation of systemic exposure through the nail plate.

Regulatory toxicology and pharmacology : RTP·2024
Same author

Editors and Journals: Part II-Relationship between the Editor-in-Chief and the Owner of the Journal: The Consequences When Editorial Independence Dissolves.

Skinmed·2023
Same author

Editors and Journals: Part I-Responsibilities And Expectations Of Editors: Who Is the Editor and Why an Editor?

Skinmed·2023

Area of Science:

  • Immunodermatology
  • Autoimmune blistering diseases
  • Mucocutaneous disorders

Background:

  • Cicatricial pemphigoid is a chronic autoimmune blistering disease.
  • It primarily affects mucous membranes and can lead to scarring.
  • Disease management often proves challenging, especially in resistant cases.

Observation:

  • The study reports on a patient with previously resistant cicatricial pemphigoid.
  • The patient's condition was characterized by chronic blistering and scarring.
  • Conventional therapies had failed to provide adequate disease control.

Findings:

  • Thalidomide was utilized as a therapeutic intervention.
  • The treatment demonstrated efficacy in controlling the resistant disease.

Related Experiment Videos

  • Scarring was a characteristic feature that the treatment aimed to manage.

    • Implications:

    • Thalidomide represents a potential treatment option for refractory cicatricial pemphigoid.
    • This finding may offer new therapeutic avenues for patients with severe or resistant disease.
    • Further research into thalidomide's role in autoimmune blistering diseases is warranted.